Caim Pharmaceutical Private Limited
About Caim Pharmaceutical Private Limited
Data last updated:
Caim Pharmaceutical Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U52310RJ2019PTC067351. Its GSTIN is 08AAICC5221G1ZV (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rakesh Mohan Agarwal and Shlok Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. 3504 Kalyan Ji Ka Rasta Chandpole Bazar, Jaipur, Rajasthan, India – 302001.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.8 Lakh, a decline of 35% compared to the previous year. For the same year it recorded a net profit of ₹15,402 (net margin 4.1%) and EBITDA of ₹69,661 (EBITDA margin 18.3%). Revenue has grown at a compounded annual rate (CAGR) of 12% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH. No. 3504 Kalyan Ji Ka Rasta Chandpole Bazar, Jaipur, Rajasthan, India – 302001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Caim Pharmaceutical Private Limited
The main business activity of Caim Pharmaceutical is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Caim Pharmaceutical Private Limited FY 2025 filings available
Caim Pharmaceutical Private Limited reported revenue of ₹3.8 Lakh (down 35% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Caim Pharmaceutical Private Limited
Revenue fell 35% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 12%. EBITDA fell 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Caim Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹69,661 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹15,402 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Caim Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Caim Pharmaceutical are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Caim Pharmaceutical Private Limited
Caim Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Retail Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nba Retail Private Limited | ₹3.81 Lakh (FY 2021) | •••• | •••• | -81.0% | •••• | Gautam Buddha Nagar, Uttar Pradesh, India |
| Oswal Soaps Private Limited | ₹3.81 Lakh (FY 2025) | •••• | •••• | -37.0% | •••• | Jaipur, Rajasthan, India |
| Dam Good Fish Private Limited | ₹3.81 Lakh (FY 2024) | •••• | •••• | •••• | Gurgaon, Haryana, India | |
| Liquistar Alcohol Private Limited | ₹3.8 Lakh (FY 2022) | •••• | •••• | •••• | Karad, Maharashtra, India | |
| Socium Pharmaceuticals Private Limited | ₹3.8 Lakh (FY 2024) | •••• | •••• | 234.0% | •••• | Delhi, India |
| Caim Pharmaceutical Private Limited this company | ₹3.8 Lakh (FY 2025) | •••• | •••• | -35.0% | •••• | Jaipur, Rajasthan, India |
| Dejunk Private Limited | ₹3.8 Lakh (FY 2025) | •••• | •••• | 19.0% | •••• | Delhi, India |
| T&T Healthcare Private Limited | ₹3.8 Lakh (FY 2025) | •••• | •••• | -33.0% | •••• | New Delhi, Delhi, India |
| Vidushi Pharmaceuticals Private Limited | ₹3.8 Lakh (FY 2022) | •••• | •••• | 2135.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Hunger Root Private Limited | ₹3.8 Lakh (FY 2023) | •••• | •••• | 179.0% | •••• | Ranchi, Jharkhand, India |
| Adore Me Fabs Marketing Private Limited | ₹3.8 Lakh (FY 2016) | •••• | •••• | -64.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Caim Pharmaceutical by revenue in the same principal business activity (Retail Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Caim Pharmaceutical Private Limited
Caim Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Mohan Agarwal | Director | 12 Dec 2019 | 6 Years 9 Months | Current |
| Shlok Agarwal | Director | 04 Mar 2023 | 3 Years 7 Months | Current |
Ownership and Shareholding of Caim Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Caim Pharmaceutical Private Limited
Caim Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Caim Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Caim Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Caim Pharmaceutical Private Limited
Caim Pharmaceutical Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Drishti Agarwal ceased to be Director on 04 Mar 2023.
Credit Ratings, Litigation & Regulatory Alerts for Caim Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Caim Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Caim Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Caim Pharmaceutical Private Limited
Caim Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAICC5221G1ZV | Rajasthan | Active | 19 Dec 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Caim Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Caim Pharmaceutical Private Limited
Caim Pharmaceutical is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 December 2019 (7+ years old) and is registered under CIN U52310RJ2019PTC067351.
Caim Pharmaceutical reported revenue of ₹3.8 Lakh for FY 2025 (down 35% YoY).
Caim Pharmaceutical has 2 current directors:
- Rakesh Mohan Agarwal - Director
- Shlok Agarwal - Director
Caim Pharmaceutical reported a net profit of ₹15,402 (net margin 4.1%) and EBITDA of ₹69,661 (EBITDA margin 18.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Caim Pharmaceutical is 12% over five years. In the latest year (FY 2025) revenue fell 35%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Caim Pharmaceutical is 08AAICC5221G1ZV, registered in Rajasthan.
The CIN (Corporate Identification Number) of Caim Pharmaceutical is U52310RJ2019PTC067351. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Caim Pharmaceutical was incorporated on 12 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Caim Pharmaceutical by revenue are Nba Retail Private Limited, Oswal Soaps Private Limited, Dam Good Fish Private Limited, Liquistar Alcohol Private Limited, Socium Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (Retail Trading).
Drishti Agarwal ceased to be Director on 04 Mar 2023. Shlok Agarwal was appointed as Director on 04 Mar 2023. Rakesh Mohan Agarwal was appointed as Director on 12 Dec 2019.
The registered office of Caim Pharmaceutical is at H. No. 3504 Kalyan Ji Ka Rasta Chandpole Bazar, Jaipur, Rajasthan, India – 302001.